Home / Recalls / Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) / D-0477-2025

D-0477-2025 Class II Ongoing

Recalled by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) — Englewood, CO

Recall Details

Product Type
Drugs
Report Date
July 2, 2025
Initiation Date
May 21, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
102 syringes

Product Description

LX Bioboost Plus, (Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine HCl 25 mg, Dexpanthenol 25 mg, Cyanocobalamin 1 mg, L-Arginine HCl 15 mg, L-Carnitine 15 mg, and Lidocaine 1 mg in SWFI), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

USA Nationwide

Code Information

Lot #: H227226, Exp 12/24/2025; H360175, Exp 6/2/2025; H368308, Exp 6/2/2025; Lot S360175, Exp 6/2/2025

Other recalls by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

  • D-0480-2025 Class II — Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, (May 21, 2025)
  • D-0478-2025 Class II — Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive H (May 21, 2025)
  • D-0476-2025 Class II — LL Bioboost Injectable, Each 1mL contains Methionine 25 mg, Inositol 50 mg, Chol (May 21, 2025)
  • D-0481-2025 Class II — Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive He (May 21, 2025)
  • D-0484-2025 Class II — Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 (May 21, 2025)
  • D-0486-2025 Class II — Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-fille (May 21, 2025)
  • D-0482-2025 Class II — Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 (May 21, 2025)
  • D-0474-2025 Class II — Methylcobalamin Injectable, 10mg/mL, pre-filled syringe, Thrive Health Solutions (May 21, 2025)
  • D-0475-2025 Class II — CJC-1295 Injectable, 6mg/15mg, pre-filled syringe, Thrive Health Solutions, 88 I (May 21, 2025)
  • D-0483-2025 Class II — Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 (May 21, 2025)